Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Kongsberg Automotive to hold fixed income investor meetings and contemplates EUR bond issue

Kongsberg, June 3, 2024: Kongsberg Automotive ASA (KA), rated B1 by Moody’s and B- by S&P, has mandated ABG Sundal Collier and Danske Bank as Joint Lead Managers & Bookrunners to arrange a series of physical and virtual fixed income investor meetings commencing on Wednesday, June 5, 2024. A new senior secured four-year bond issue may follow, subject to inter alia market conditions. The net proceeds from the contemplated bond issue will be used, together with available cash, to refinance the outstanding senior secured bonds due on July 15, 2025 (Existing Bonds). The Existing Bonds are

Epiroc appoints Jodie Velasquez President Parts & Services APAC division

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and construction industries, has appointed Jodie Velasquez President of the Parts & Services Asia Pacific (APAC) division and member of Group Management, effective immediately.Jodie Velasquez has a 16-year career with the company and her significant experience includes serving as General Manager for production companies in Canada and Australia, Business Controller and Plant Manager. She has been Vice President Controlling and Finance for Epiroc’s three regional Parts & Services divisions since

Cereno Scientific initiates collaboration with the Pulmonary and Vascular Research Institute (PVRI)

Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, with its lead program CS1 currently being evaluated in a Phase II clinical study in the rare disease Pulmonary Arterial Hypertension (PAH), today announced that the Company will join the PVRI Roundtable (Pulmonary and Vascular Research Institute). Cereno will, amongst other things, participate in PVRI’s Innovative Drug Development Initiative (IDDI), addressing the most challenging issues faced by pharma, researchers, regulators, and clinicians and

Callio project strengthened as Dovre Group Plc joins the consortium to engage in the 85 MW BESS solution

Sustainable Energy Solutions Sweden Holding AB (“SENS” or the “Company”) announces a reinforcement of its Callio project in Pyhäjärvi, Finland, as Dovre Group Plc joins the consortium to engage in one of three projects within the scope of the total project. Dovre Group Plc has decided to engage in the 85 MW Battery Energy Storage System (BESS) project through an acquisition of parts of the special purpose vehicle being set up specifically for the BESS.SENS is pleased to announce that it is expanding the project in Pyhäjärvi, which it is undertaking in co-operation with Callio, a Finnish

Crunchfish Gesture Interaction releases XR Skeleton 3.0

Crunchfish Gesture Interaction announces a new generation of the XR Skeleton flagship product. The new version combines earlier products for single and stereo cameras into one powerful product. Support for OpenXR is also included, enabling platform independent development of gesture applications.   Crunchfish has released XR Skeleton 3.0 to customers and partners. This is the third generation of the XR Skeleton flagship product, which now combines earlier products for single and stereo cameras into one powerful product. The new release provides state of the art hand tracking

Teleste's CFO Juha Hyytiäinen will leave his position

Teleste CorporationPress releaseJune 3, 2024, at 9:30 a.m. EESTTELESTE´S CFO JUHA HYYTIÄINEN WILL LEAVE HIS POSITION Teleste´s CFO and member of the management team Juha Hyytiäinen has decided to leave Teleste Corporation for new responsibilities at another company. Mr. Hyytiäinen will continue in his position and as a member of Teleste's management team until the end of August to ensure a smooth transition and transfer of duties. The recruitment process for the new CFO has started. In addition, from mid-August, Mr. Tomi Närhinen M.Sc. (Econ) from outside the company will assume

Wihlborgs signs new leases for growing life science node Medeon in Malmö

The medical technology company Rubin Medical is set to move in to Medeon (Forskaren 1) in the summer and the existing tenant Swedencare is expanding at the same location. The leases encompass approximately 1,000 square metres.Rubin Medical markets and distributes high-tech devices for patients with type 1 diabetes and has been part of the Indutrade technology Group since 2012. The lease at Medeon encompasses 840 square metres and extends for five years, with occupancy on 1 August. Swedencare, which manufactures food supplements for dogs, cats and horses, already has its head office

ABS 2024 Outlook Highlights Active Shift in Fleet Composition Toward More Sustainable Fuel Alternatives

(ATHENS) According to the latest ABS research, geopolitical instability, scalability of fuel production and retrofits to existing vessels are key factors impacting the shipping industry’s journey to net zero by 2050. The sixth in an annual series, the 2024 Outlook: Beyond the Horizon, Carbon Neutral Fuel Pathways and Transformational Technologies, investigates carbon-neutral fuel pathways and transformative technologies and features an update of ABS’ long-term energy forecast that explores the constraints and opportunities in the evolving global trade dynamics that will shape

Ericsson announces conclusion of Monitorship

· Ericsson's Monitorship and Plea Agreement concluded on June 2 · Follows upon certification of Ericsson’s anti-corruption compliance program by independent Monitor in March 2024 · Continuing to cooperate fully with DOJ and SEC investigations on historical conductEricsson (NASDAQ: ERIC) today announces the conclusion of the work and term of the independent compliance Monitor appointed by the U.S Department of Justice (DOJ) in June of 2020 in connection with Ericsson’s 2019 Deferred Prosecution Agreement (DPA) to resolve historical violations of the Foreign Corrupt Practices Act (FCPA).

Corem has signed a 5-year agreement with Freemelt of approximately 1,500 sq.m. in Gothenburg

  Corem has signed a 5-year lease with the 3D printer company Freemelt of 1,511 square meters in the property Majorna 219:7 in Gothenburg. The premises will house headquarters with central management functions as well as product management, innovation and application centers. Move-in is planned for the fourth quarter of 2024. "Freemelt is now switching up the company's strategy with commercialization and industrialization, which results in a growing organization and a need of new types of competence. An innovative and inspiring work environment is an important piece of the

Michael Grissinger appointed as new Chairman of AnaCardio

PRESS RELEASE Stockholm, Sweden, June 3, 2024 AnaCardio, a Swedish clinical-stage biopharmaceutical company focusing on developing novel contractile agents to treat patients with heart failure, announces today the appointment of Michael Grissinger, B.S M.B.A. as new chairman of the board.Michael has had a long and successful career in the pharmaceutical industry, leading large value business development transactions across multiple therapeutic areas and products. Michael spent more than two decades at Johnson & Johnson, holding positions of Vice President and Head, Worldwide

Assemblin performs extensive power projects at treatment plant

Assemblin has signed an agreement with Veidekke regarding power installations in connection with the expansion of Stockholm Vatten och Avfalls (Stockholm Water and Waste’s) treatment plant in Sickla. The value of the order amounts to approximately SEK 130 million and will be performed by Assemblin’s industrial and power operations.The Sickla plant, which forms one part of the Henriksdal treatment plant, is being expanded and modernised to meet the needs of a growing city, with new and efficient technology while, at the same time, meeting increased environmental requirements. “The

Africa Oil Announces Results of Share Buyback Program and Provides Share Capital and Voting Rights Update

VANCOUVER, BC, June 3, 2024 /CNW/ - (AOI–TSX, AOI–Nasdaq-Stockholm) – Africa Oil Corp. (“Africa Oil”, or the “Company”) is pleased to announce that the Company repurchased a total of 1,138,400 Africa Oil common shares during the period of May 27, 2024 to May 31, 2024 under the previously announced share buyback program. The launch of Africa Oil’s normal course issuer bid (share buyback) program, announced by the Company on December 4, 2023, is being implemented in accordance with the Market Abuse Regulation (EU) No 596/2014 (MAR) and Commission Delegated Regulation (EU) No 2016/1052 (

Tagrisso plus chemo recommended for approval in EU

3 June 2024 Tagrisso with the addition of chemotherapy recommended for approval inthe EU by CHMP for patients with EGFR-mutated advanced lung cancer  Recommendation based on FLAURA2 results which showed Tagrisso plus chemotherapy extended median progression-free survival by nearly 9 months vs. standard of care AstraZeneca's Tagrisso (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy has been recommended for approval in the European Union (EU) for 1st-line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor-

Matsmart-Motatos' consolidated results in 2023: Turnover of over 1 billion SEK with improved cash flow

On 30 May 2024, the annual and sustainability report for 2023 was adopted by the Annual General Meeting with shareholders. Growth during the year was 17 per cent and the transition to profitability has taken effect. Below is a summary of the highlights of the year.Jan - Dec 2023 financial key figures ·   The Group's turnover totalled SEK 1043 million, an increase of 17% (23%) compared with 2022 (SEK 889 million). o   Nordics: turnover totalled SEK 678 (605) million o   DACH: turnover totalled SEK 334 (267) million o   United Kingdom: turnover totalled SEK 31 (18) million ·

Pär Vennerström Business Unit Manager for JM Property Development

Pär Vennerström, who has been the business unit manager for JM Residential Stockholm since 2014, will also take over as of June 1, 2024, as business unit manager for JM Property Development. This is as a result of Mikael Åslund, former business unit manager for JM Property Development, taking over as President and CEO of JM.JM’s Property Development business unit develops rental units, residential care units, and commercial premises, and is responsible for the property management business JM@home. Pär Vennerström has extensive experience with JM and of working in JM’s executive management

Genetic Analysis AS: Mandatory notification of trade – Primary Insider

OSLO, NORWAY – 3 June 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the board of directors has bought GEAN-shares.Jethro Holter, Chairperson of Genetic Analysis AS, has on Friday 31.05.2024 bought 13.000 GEAN shares at an average price of 0,70 NOK per share. The shares were acquired on the Spotlight Stock Market. Following the transaction, Jethro Holter owns 30.898 shares in the Company.

Transaction in Own Shares

    3 June 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |31/05/2024|+---------------------------------------------------------------

HANZA continues the strategy work following the Orbit One integration

HANZA has completed the integration and efficiency program launched in March 2024 and is now considering the next steps in the strategy ”HANZA 2025”. While new factories are being completed in Estonia and Sweden, HANZA initiates union negotiations in Sweden and an employee consultation process in Finland regarding the proposed closure of two smaller production units during 2024. The purpose is to consolidate customer volumes to further increase operational efficiency and customer value.In January, HANZA completed the acquisition of Orbit One, the company’s largest acquisition to date. To

Bl-Weekly Status Report

MYDECINE PROVIDES Bl-WEEKLY STATUS REPORT Vancouver, British Columbia, June 3, 2024— Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) (AQSE: MYIG) provides this update on the status of a management cease trade order granted on May 2, 2024 (the "MCTO") by the British Columbia Securities Commission under National Policy 12-203 – Management Cease Trade Order ("NP 12-203"). On May 3, 2024, the Company announced that, for reasons disclosed in the news release, there would be a delay in the filing of its financial statements and accompanying management’s

Gaming Innovation Group expands its reach in online gaming with the acquisition of Casinomeister

Gaming Innovation Group Inc. (GiG), a leader in digital marketing and media within the online gaming sector, today announce the strategic acquisition of Casinomeister, a pioneering online casino advocacy and review platform. Casinomeister has been at the forefront of promoting transparency and fairness in gaming over the last 25 years. Following the successful integration of AskGamblers and KaFe Rocks, this acquisition further solidifies GiG Media’s commitment to enhancing transparency and improving player services across the online gaming industry, instilling confidence in our values.

Chromatin openness sheds new light on prostate cancer plasticity

Treatment resistance caused by cancer cell plasticity constitutes a major challenge in the treatment of prostate cancer. Published in Nucleic Acids Research, a recent study from the University of Eastern Finland Institute of Biomedicine suggests that the SIX2 protein may be a possible factor underlying increased plasticity of prostate cancer cells and treatment resistance. Prostate cancer is the most common cancer in men and the second most common cause of cancer mortality in Western countries. Prostate cancer growth is promoted by androgens and can be treated with androgen receptor

There are no items matching the current filter
There are no more items matching the current filter
Back to top